https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-bonuses-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-environmental-loss-contingencies-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-payroll-taxes-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-rent-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-salaries-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accrued-salaries-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/acquired-equipment https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/acquired-intangibles https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/acquisition-costs-cumulative https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/adjustment-for-amortization https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/administrative-fees-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/amortization-expense-per-dollar-of-gross-revenue https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/assets-average-outstanding https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/buybacks-payments-for-repurchase-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-change https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/change-in-unrealized-gain-loss-on-fair-value-hedging-instruments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/commitments-and-contingencies https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/concentration-risk-credit-risk-financial-instrument-maximum-exposure https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/contractual-obligation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-debt-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-notes-payable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/convertible-preferred-stock-converted-to-other-securities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/debt-redemption-price-percentage-of-principal-amount-redeemed https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-costs-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deferred-tax-liabilities-deferred-expense-capitalized-patent-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deposits-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/disposal-group-including-discontinued-operation-intangible-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/dividends-cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/dividends-declared https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/dividends-preferred-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/dividends-preferred-stock-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/due-to-other-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/equity-method-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/exploration-costs-cumulative https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/federal-deposit-insurance-corporation-premium-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finite-lived-intangible-assets-acquired https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/gain-loss-on-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/haircuts-on-contractual-securities-commitments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-other-loans https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/initial-franchise-fees https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/insured-event-gain-loss https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-expense-trust-preferred-securities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/investment-options-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/labor-and-related-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/loans-payable-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/loss-on-contracts https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-income-loss-allocated-to-limited-partners https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/noncash-contribution-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/officers-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-income-2 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-intangible-assets-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-operating-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-receivables-net-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/paid-in-capital-shares-issued-ownshare-lending-arrangement-issuance-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/partners-capital-account-public-sale-of-units-net-of-offering-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-conversions-inducements https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-fees-received https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/product-warranty-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/professional-and-contract-services-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/property-plant-and-equipment-other-accumulated-depreciation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/reinsurance-loss-on-uncollectible-accounts-in-period-amount https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/restricted-stock-award-forfeitures-dividends https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/salaries-and-wages https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/security-deposit https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shares-issued-2 https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shares-issued-value-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/shares-repurchased-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/subscription-revenue https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/weighted-average-number-of-shares-restricted-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/weighted-average-number-of-shares-treasury-stock https://stock.noler.com/us/stock/innovation-pharmaceuticals-inc/write-off-of-deferred-debt-issuance-cost